Loading...
Keywords
Last Name
Institution

Keith J. August, MD, MS

TitleSection Chief, Oncology
InstitutionChildren's Mercy Kansas City
DepartmentHematology/Oncology/BMT
Address2401 Gillham Rd
Kansas City MO 64108
vCardDownload vCard
    Other Positions
    TitleDirector, Leukemia & Lymphoma Program
    InstitutionChildren's Mercy Kansas City
    DepartmentHematology/Oncology/BMT

    TitleAssociate Director, Experimental Therapeutics in Pediatric Cancer Program
    InstitutionChildren's Mercy Kansas City
    DepartmentHematology/Oncology/BMT

    TitleProfessor
    InstitutionUniversity of Missouri-Kansas City
    DepartmentPediatrics

    TitleClinical Assistant Professor
    InstitutionUniversity of Kansas Medical Center
    DepartmentPediatrics


    Collapse Biography 
    Collapse education and training
    University of Oklahoma College of Medicine, Oklahoma City, OKMD2002
    University of Louisville/Kosair Children's Hospital, Louisville, KYResidency2005Pediatrics
    Emory University School of Medicine/Children's Healthcare of Atlanta, Atlanta, GAFellowship2008Pediatric Hematology/Oncology

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Marks LJ, Ritter V, Agrusa JE, Kamdar KY, Rivers J, Gardner R, Ehrhardt MJ, Devine KJ, Phillips CA, Reilly A, August K, Weinstein J, Satwani P, Forlenza CJ, Smith CM, Greer C, Afify Z, Lin CH, Belsky JA, Ding H, Hoogstra D, Toner K, Link MP, Schultz LM, Lowe EJ, Aftandilian C. Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365. PMID: 39841960.
      View in: PubMed
    2. Lansdon LA, Yoo B, Keskus A, Pushel I, Bi C, Ahmad T, Bryant A, Walter A, Gibson M, Rindler M, Li W, Habeebu SM, Cooley LD, Herriges J, Repnikova E, Zhang L, August KJ, Flatt TG, Gamis AS, Guest EM, Hays JA, Hetherington M, Lewing K, Pastinen T, Kolmogorov M, Farooqi MS. Successful classification of clinical pediatric leukemia genetic subtypes via structural variant detection using HiFi long-read sequencing. medRxiv. 2024 Nov 05. PMID: 39802758.
      View in: PubMed
    3. Witek MA, Larkey NE, Bartakova A, Hupert ML, Mog S, Cronin JK, Vun J, August KJ, Soper SA. Microfluidic Affinity Selection of B-Lineage Cells from Peripheral Blood for Minimal Residual Disease Monitoring in Pediatric B-Type Acute Lymphoblastic Leukemia Patients. Int J Mol Sci. 2024 Oct 02; 25(19). PMID: 39408948.
      View in: PubMed
    4. Childers K, Freed IM, Hupert ML, Shaw B, Larsen N, Herring P, Norton JH, Shiri F, Vun J, August KJ, Witek MA, Soper SA. Novel thermoplastic microvalves based on an elastomeric cyclic olefin copolymer. Lab Chip. 2024 09 10; 24(18):4422-4439. PMID: 39171671.
      View in: PubMed
    5. Bates CR, Gilbert RM, Dean KM, August KJ, Befort CA, Ward S, Gibson M, Dreyer Gillette ML. Tailored approach to participant recruitment and retention to maximize health equity in pediatric cancer research. BMC Med Res Methodol. 2024 Jul 24; 24(1):161. PMID: 39049026.
      View in: PubMed
    6. Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood. 2024 05 16; 143(20):2053-2058. PMID: 38457359.
      View in: PubMed
    7. Tokala M, Weber J, Gilbert R, Dreyer Gillette ML, August KJ, Befort CA, Bates CR. Caregiver perceptions of child heath behaviors and weight during treatment for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Jun; 71(6):e30984. PMID: 38584336.
      View in: PubMed
    8. Bates CR, Staggs VS, Dean KM, August KJ, Befort CA, Covitz LM, Dreyer Gillette ML. Family Rules and Routines During the Early Phases of Pediatric Cancer Treatment: Associations With Child Emotional and Behavioral Health. J Pediatr Psychol. 2024 01 19; 49(1):66-76. PMID: 37990581.
      View in: PubMed
    9. Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA. Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. J Clin Oncol. 2022 07 01; 40(19):2106-2118. PMID: 35271306.
      View in: PubMed
    10. Lee B, Yin D, August K, Noel-Macdonell J, Tracy M, Jensen D. Clinical predictors of invasive fungal rhinosinusitis in a tertiary pediatric hospital. Int J Pediatr Otorhinolaryngol. 2022 Apr; 155:111065. PMID: 35183919.
      View in: PubMed
    11. Thudium Mueller K, Grupp SA, Maude SL, Levine JE, Pulsipher MA, Boyer MW, August KJ, Myers GD, Tam CS, Jaeger U, Foley SR, Borchmann P, Schuster SJ, Waller EK, Awasthi R, Potthoff B, Warren A, Waldron ER, McBlane F, Chassot-Agostinho A, Laetsch TW. Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Blood Adv. 2021 12 14; 5(23):4980-4991. PMID: 34432863.
      View in: PubMed
    12. Levine JE, Grupp SA, Pulsipher MA, Dietz AC, Rives S, Myers GD, August KJ, Verneris MR, Buechner J, Laetsch TW, Bittencourt H, Baruchel A, Boyer MW, De Moerloose B, Qayed M, Davies SM, Phillips CL, Driscoll TA, Bader P, Schlis K, Wood PA, Mody R, Yi L, Leung M, Eldjerou LK, June CH, Maude SL. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. J Immunother Cancer. 2021 08; 9(8). PMID: 34353848.
      View in: PubMed
    13. O'Brien MM, Alonzo TA, Cooper TM, Levine JE, Brown PA, Slone T, August KJ, Benettaib B, Biserna N, Poon J, Patturajan M, Chen N, Simcock M, Zimmerman L, Kolb EA. Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia. Pediatr Blood Cancer. 2021 07; 68(7):e28946. PMID: 33694257.
      View in: PubMed
    14. Hall EM, Yin DE, Goyal RK, Ahmed AA, Mitchell GS, St Peter SD, Flatt TG, Ahmed IA, Li W, Hendrickson RJ, August KJ, Myers GD. Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. J Immunother Cancer. 2021 01; 9(1). PMID: 33472856.
      View in: PubMed
    15. Zerr DM, Milstone AM, Dvorak CC, Adler AL, Chen L, Villaluna D, Dang H, Qin X, Addetia A, Yu LC, Conway Keller M, Esbenshade AJ, August KJ, Fisher BT, Sung L. Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology Group. Cancer. 2021 01 01; 127(1):56-66. PMID: 33079403.
      View in: PubMed
    16. Perry JM, Tao F, Roy A, Lin T, He XC, Chen S, Lu X, Nemechek J, Ruan L, Yu X, Dukes D, Moran A, Pace J, Schroeder K, Zhao M, Venkatraman A, Qian P, Li Z, Hembree M, Paulson A, He Z, Xu D, Tran TH, Deshmukh P, Nguyen CT, Kasi RM, Ryan R, Broward M, Ding S, Guest E, August K, Gamis AS, Godwin A, Sittampalam GS, Weir SJ, Li L. Overcoming Wnt-?-catenin dependent anticancer therapy resistance in leukaemia stem cells. Nat Cell Biol. 2020 06; 22(6):689-700. PMID: 32313104.
      View in: PubMed
    17. M Weerakoon-Ratnayake K, Vaidyanathan S, Larky N, Dathathreya K, Hu M, Jose J, Mog S, August K, K Godwin A, L Hupert M, A Witek M, A Soper S. Microfluidic Device for On-Chip Immunophenotyping and Cytogenetic Analysis of Rare Biological Cells. Cells. 2020 02 24; 9(2). PMID: 32102446.
      View in: PubMed
    18. Zhang L, Brown LE, Bowen LM, McCarthy LC, Cooley LD, Repnikova E, Gener MA, Garola R, August KJ, Hays JA, Zwick DL, Li W. Application of 2016 WHO classification in the diagnosis of paediatric high-grade MYC-negative mature B-cell lymphoma with Burkitt-like morphological features. J Clin Pathol. 2020 Sep; 73(9):563-570. PMID: 31964683.
      View in: PubMed
    19. Shah NN, Bhojwani D, August K, Baruchel A, Bertrand Y, Boklan J, Dalla-Pozza L, Dennis R, Hijiya N, Locatelli F, Martin PL, Mechinaud F, Moppett J, Rheingold SR, Schmitt C, Trippett TM, Liang M, Balic K, Li X, Vainshtein I, Yao NS, Pastan I, Wayne AS. Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020 05; 67(5):e28112. PMID: 31944549.
      View in: PubMed
    20. August KJ, Guest EM, Lewing K, Hays JA, Gamis AS. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib. Pediatr Blood Cancer. 2020 03; 67(3):e28062. PMID: 31724803.
      View in: PubMed
    21. August KJ, Farooki S, Fulbright JM, August A, Portnoy JM, Pommert L, Burke MJ, Guest EM. Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma. Pediatr Blood Cancer. 2020 01; 67(1):e28021. PMID: 31571395.
      View in: PubMed
    22. Li W, Cooley LD, August KJ, Richardson AI, Shao L, Ahmed AA, Farooqi MS, Zwick DL. Cuplike nuclear morphology is highly associated with IKZF1 deletion in pediatric precursor B-cell ALL. Blood. 2019 07 18; 134(3):324-329. PMID: 31076445.
      View in: PubMed
    23. Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR. Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 Apr; 33(4):1061-1062. PMID: 30842605.
      View in: PubMed
    24. Stein AM, Grupp SA, Levine JE, Laetsch TW, Pulsipher MA, Boyer MW, August KJ, Levine BL, Tomassian L, Shah S, Leung M, Huang PH, Awasthi R, Mueller KT, Wood PA, June CH. Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells. CPT Pharmacometrics Syst Pharmacol. 2019 05; 8(5):285-295. PMID: 30848084.
      View in: PubMed
    25. Locatelli F, Mauz-Koerholz C, Neville K, Llort A, Beishuizen A, Daw S, Pillon M, Aladjidi N, Klingebiel T, Landman-Parker J, Medina-Sanson A, August K, Sachs J, Hoffman K, Kinley J, Song S, Song G, Zhang S, Suri A, Gore L. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematol. 2018 Oct; 5(10):e450-e461. PMID: 30290902.
      View in: PubMed
    26. Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR. Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892. PMID: 30267011.
      View in: PubMed
    27. Mueller KT, Waldron E, Grupp SA, Levine JE, Laetsch TW, Pulsipher MA, Boyer MW, August KJ, Hamilton J, Awasthi R, Stein AM, Sickert D, Chakraborty A, Levine BL, June CH, Tomassian L, Shah SS, Leung M, Taran T, Wood PA, Maude SL. Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia. Clin Cancer Res. 2018 12 15; 24(24):6175-6184. PMID: 30190371.
      View in: PubMed
    28. Bartholomew JL, Dai H, August KJ, Ryan RE, Stegenga KA. Feasibility of Outpatient High-Dose Methotrexate Infusions in Pediatric Patients With B-Lineage Acute Lymphoblastic Leukemia. J Adv Pract Oncol. 2018 May-Jun; 9(4):381-386. PMID: 30719391.
      View in: PubMed
    29. Li W, Cooley LD, August K. Juvenile myelomonocytic leukemia with t(3;5)(q25;q35), Auer rods and marked myelodysplasia. Pathol Res Pract. 2018 Jun; 214(6):919-923. PMID: 29496305.
      View in: PubMed
    30. Jones GL, McClellan W, Raman S, Sherman A, Guest E, August K. Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2017 07; 39(5):370-375. PMID: 28538500.
      View in: PubMed
    31. Cooper TM, Sison EAR, Baker SD, Li L, Ahmed A, Trippett T, Gore L, Macy ME, Narendran A, August K, Absalon MJ, Boklan J, Pollard J, Magoon D, Brown PA. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03). Pediatr Blood Cancer. 2017 Aug; 64(8). PMID: 28409853.
      View in: PubMed
    32. Tolbert JA, Bai S, Abdel-Rahman SM, August KJ, Weir SJ, Kearns GL, Neville KA. Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017 Aug; 64(8). PMID: 28295989.
      View in: PubMed
    33. Villanueva MA, August KJ. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever. Pediatr Blood Cancer. 2016 10; 63(10):1829-33. PMID: 27196265.
      View in: PubMed
    34. Cooper TM, Cassar J, Eckroth E, Malvar J, Sposto R, Gaynon P, Chang BH, Gore L, August K, Pollard JA, DuBois SG, Silverman LB, Oesterheld J, Gammon G, Magoon D, Annesley C, Brown PA. A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Clin Cancer Res. 2016 Aug 15; 22(16):4014-22. PMID: 26920889.
      View in: PubMed
    35. Mueller EL, Hall M, Shah SS, August KJ, Radhi MA, Macy ML. Characteristics of Children With Cancer Discharged or Admitted From the Emergency Department. Pediatr Blood Cancer. 2016 May; 63(5):853-8. PMID: 26713542.
      View in: PubMed
    36. August KJ, Chiang KY, Qayed M, Dulson A, Worthington-White D, Cole CR, Horan JT. Relative defects in mucosal immunity predict acute graft-versus-host disease. Biol Blood Marrow Transplant. 2014 Jul; 20(7):1056-9. PMID: 24641826.
      View in: PubMed
    37. August KJ, Miller WP, Dalton A, Shinnick S. Comparison of hypersensitivity reactions to PEG-asparaginase in children after intravenous and intramuscular administration. J Pediatr Hematol Oncol. 2013 Oct; 35(7):e283-6. PMID: 23619117.
      View in: PubMed
    38. Held K, Ryan R, Champion JM, August K, Radhi MA. Caregiver survey results related to handling of oral chemotherapy for pediatric patients with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2013 Aug; 35(6):e249-53. PMID: 23274379.
      View in: PubMed
    39. Qayed M, Langston A, Chiang KY, August K, Hilinski JA, Cole CR, Rogatko A, Bostick RM, Horan JT. Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation. J Pediatr Hematol Oncol. 2013 May; 35(4):e149-52. PMID: 23274384.
      View in: PubMed
    40. August KJ, Narendran A, Neville KA. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions. Drugs. 2013 Apr; 73(5):439-61. PMID: 23568274.
      View in: PubMed
    41. Fulbright JM, Raman S, McClellan WS, August KJ. Late effects of childhood leukemia therapy. Curr Hematol Malig Rep. 2011 Sep; 6(3):195-205. PMID: 21695425.
      View in: PubMed
    42. August KJ, Dalton A, Katzenstein HM, George B, Olson TA, Wasilewski-Masker K, Rapkin LB. The use of zoledronic acid in pediatric cancer patients. Pediatr Blood Cancer. 2011 Apr; 56(4):610-4. PMID: 21298747.
      View in: PubMed
    43. August KJ, Chiang KY, Bostick RM, Flanders WD, Waller EK, Langston A, Worthington-White D, Rowland P, Moore KF, Khoury HJ, Horan JT. Biomarkers of immune activation to screen for severe, acute GVHD. Bone Marrow Transplant. 2011 Apr; 46(4):601-4. PMID: 20622904.
      View in: PubMed
    44. Adamovich SV, August K, Merians A, Tunik E. A virtual reality-based system integrated with fmri to study neural mechanisms of action observation-execution: a proof of concept study. Restor Neurol Neurosci. 2009; 27(3):209-23. PMID: 19531876.
      View in: PubMed
    August's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (215) concept(s)
    _
    Co-Authors Expand Description
    See all (14) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department